Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oclassen Pharmaceuticals Inc.

Division of Allergan PLC

Latest From Oclassen Pharmaceuticals Inc.

A Precarious Union: Combining Proprietary and Generic Businesses

The major generics companies, flush with cash from the recent plethora of patent expirations, are all forging ahead in the proprietary business in order to boost margins and even out the volatile revenues and earnings inherent in their core business. They're pursuing, by and large, strategies that don't take them far from their core expertise and involve reformulating known compounds. Some companies have had moderate success, but weaving together two such disparate businesses is a challenge.
BioPharmaceutical Strategy

Say Good-bye to the Family Farm

Watson Pharmaceuticals Inc.'s purchase of Schein Pharmaceutical seems to confirm what generics industry experts have known for some time: the industry is consolidating at both the wholesaler and manufacturer levels. The purchase, for $674 million and the assumption of $240 million in debt, is the third time in the past year that a large generics maker has bought a rival. The deal puts Watson, now ranked number four in generics, in a race for first place with Teva Pharmaceutical Industries Inc., which has also been on a buying spree.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Terry Johnson, Pres. & CEO
    Kirk D Petersen, VP, Fin. & Admin. & CFO
    William G Thomas, Dir., Bus. Dev.
    Anthony DiTonno, VP, Mktg. & Sales
    Frank P Killey, PhD, VP, R&D
  • Contact Info
  • Oclassen Pharmaceuticals Inc.
    Phone: (415) 258-4500
    100 Pelican Way
    San Rafael, CA 94901
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register